Immunocore to present at upcoming investor conferences

Immunocore to present at upcoming investor conferences GlobeNewswire November 10, 2025 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, November 10, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, […]

Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeting

Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeting GlobeNewswire November 10, 2025 CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company accelerating potential high-impact therapies in autoimmune diseases and cancer, today announced its management team will

Fury Drilling at Committee Bay Extends Three Bluffs Mineralization and Expands Raven Target

(TSX:FURY),(NYSE MKT:FURY), TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company“) announces the results from the 2025 exploration drilling program at the Committee Bay project, located in the eastern Kitikmeot region of Nunavut, Canada (Figure 1). The 2025 drilling program comprised six (6) diamond

Fury Drilling at Committee Bay Extends Three Bluffs Mineralization and Expands Raven Target

Fury Drilling at Committee Bay Extends Three Bluffs Mineralization and Expands Raven Target GlobeNewswire November 10, 2025 TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company“) announces the results from the 2025 exploration drilling program at the Committee Bay project, located in the eastern

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the third quarter ended September 30, 2025, and provided a review of recent accomplishments and anticipated upcoming

TreeHouse Foods and Investindustrial Announce Definitive Acquisition Agreement for a Total Enterprise Value of $2.9 Billion

TreeHouse Foods Shareholders to Receive $22.50 Per Share in Cash and One Contingent Value Right Per Share TreeHouse Foods, Inc. (NYSE: THS, “TreeHouse Foods” or “the Company”) and Industrial F&B Investments III Inc. (“Investindustrial”), an independently managed investment subsidiary of Investindustrial VIII SCSp, part of a leading European group of independently managed investment, holding, and

TreeHouse Foods, Inc. Reports Third Quarter 2025 Results

Announces Transaction with Investindustrial — Net sales were $840.3 million, and adjusted net sales1 were $841.9 million. — Net loss was $265.8 million, which included a non-cash goodwill impairment loss of $289.7 million. — Adjusted EBITDA1 of $91.6 million. TreeHouse Foods, Inc. (NYSE: THS) today reported financial results for the third quarter of 2025. THIRDQUARTER

NextVision Reports a Record Third Quarter 2025

62% Year-Over-Year Revenue Growth to $47 Million & Strong Profitability; Order Backlog as of today at $124 Million NextVision Stabilized Systems Ltd. (TASE: NXSN), a leading global provider of stabilized day- and night-vision imaging solutions for aerial and ground platforms such as micro and mini UAVs and drones, today announced its financial results for the

CMG Signs Global Multi-Year Simulation Software Licensing Agreement

(TSX:CMG), CALGARY, Alberta, Nov. 10, 2025 (GLOBE NEWSWIRE) — Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) today announced that it has entered into a multi-year software licensing agreement with Shell for CMG's suite of simulation solutions, including CoFlowTM, the industry's first enterprise solution integrating reservoir and production simulation workflows. This agreement represents

Scroll to Top